To conclude, AKIP1 is overexpressed in tumor tissues compared with non‐cancerous tissues; meanwhile, tumor AKIP1 high expression correlates with deteriorative tumor features and predicts worse survival profiles in gastric cancer patients, which imply that AKIP1 may serve as a potential biomarker for advanced progression and poor prognosis of gastric cancer. This evidence concerns the gene AKIP1 and gastric cancer.